$154.450
+7.460 (+4.83%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
BLTE 相似圖表分析預測
Alphio's BLTE stock price prediction model matches the current Belite Bio, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $153.43 (-0.66%). The 1-week path is $160.23 (+3.74%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Belite Bio, Inc 股票嗎?
Belite Bio Inc is not a good buy right now due to its current price of $142.78, which is significantly below the analyst price targets ranging from $234 to $303. However, the stock has a very low RSI of 19.27, indicating it is oversold, but the negative catalysts such as consistent losses, with a forward P/E of 416.67 and a 5-day change of -7.58% suggest that the risks outweigh the potential upside at this moment.
BLTE 股價於 Tuesday 收在 $154.45,此前上漲 +4.83%
Belite Bio, Inc (BLTE) last closed at $154.45, gaining +4.83%. These facts feed the 1-day and 1-week BLTE price prediction above.
預測驅動因素
Belite Bio, Inc(BLTE)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 BLTE 最接近的股票,依相似度排序。
BLTE 季節性分析
Historically the probability of a positive October return for BLTE is 80.00%. November offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
BLTE 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Oct 2026 | $65.23 | $70.88 | $78.93 | -54.11% |
| Nov 2026 | $62.14 | $63.40 | $63.95 | -58.95% |
| Dec 2026 | $65.08 | $68.82 | $77.60 | -55.44% |
2026 年,Belite Bio, Inc(BLTE)預計區間為 $62.14 至 $78.93。
Belite Bio, Inc 2026 年月度預測
2026 年 Oct,Belite Bio, Inc 預計均價 $70.88,最低 $65.23,最高 $78.93。
2026 年 Nov,Belite Bio, Inc 預計均價 $63.40,最低 $62.14,最高 $63.95。
2026 年 Dec,Belite Bio, Inc 預計均價 $68.82,最低 $65.08,最高 $77.60。
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。